(Q33499869)

English

Treatment of advanced pancreatic carcinoma with a combination of protracted infusional 5-fluorouracil and weekly carboplatin: a Mid-Atlantic Oncology Program Study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 July 2017

Treatment of advanced pancreatic carcinoma with a combination of protracted infusional 5-fluorouracil and weekly carboplatin: a Mid-Atlantic Oncology Program Study (English)

1 reference

Europe PubMed Central

27 July 2017

pancreatic carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

M Auerbach

1

1 reference

Europe PubMed Central

27 July 2017

G L Wampler

2

1 reference

Europe PubMed Central

27 July 2017

J J Lokich

3

1 reference

Europe PubMed Central

27 July 2017

D Fryer

4

1 reference

Europe PubMed Central

27 July 2017

J G Fryer

5

1 reference

Europe PubMed Central

27 July 2017

J D Ahlgren

6

1 reference

Europe PubMed Central

27 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 May 1997

1 reference

Europe PubMed Central

27 July 2017

Annals of Oncology

1 reference

Europe PubMed Central

27 July 2017

8

1 reference

Europe PubMed Central

27 July 2017

5

1 reference

Europe PubMed Central

27 July 2017

439-444

1 reference

Europe PubMed Central

27 July 2017

Estimates of the worldwide incidence of eighteen major cancers in 1985.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008299429294

7 January 2021

based on heuristic

inferred from DOI database lookup

Current status of chemotherapy for advanced pancreatic and gastric cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008299429294

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy for pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008299429294

7 January 2021

based on heuristic

inferred from DOI database lookup

5-fluorouracil, Adriamycin, and mitomycin-C (FAM) chemotherapy for advanced adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008299429294

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of streptozotocin, mitomycin-C and 5-fluorouracil (SMF) in the treatment of advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008299429294

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II studies of drug combinations in advanced pancreatic carcinoma: fluorouracil plus doxorubicin plus mitomycin C and two regimens of streptozotocin plus mitomycin C plus fluorouracil. The Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008299429294

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy for advanced pancreatic cancer. A comparison of 5-fluorouracil, adriamycin, and mitomycin (FAM) with 5-fluorouracil, streptozotocin, and mitomycin (FSM).

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008299429294

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008299429294

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008299429294

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of squamous-cell carcinoma of the head and neck with cisplatin and 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008299429294

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008299429294

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of combined 5-fluorouracil, doxorubicin, and cisplatin in the treatment of advanced upper gastrointestinal adenocarcinomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008299429294

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008299429294

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective randomized comparison of protracted infusional 5-fluorouracil with or without weekly bolus cisplatin in metastatic colorectal carcinoma. A Mid-Atlantic Oncology Program study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008299429294

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuous infusion 5-fluorouracil plus weekly cisplatin for pancreatic carcinoma. A Mid-Atlantic Oncology Program study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008299429294

7 January 2021

based on heuristic

inferred from DOI database lookup

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008299429294

7 January 2021

based on heuristic

inferred from DOI database lookup

Pyridoxine for the palmar-plantar erythrodysesthesia syndrome

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008299429294

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008299429294

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase II clinical trial of adriamycin, methotrexate, and actinomycin-d in advanced measurable pancreatic carcinoma.A gastrointestinal tumor study group report

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008299429294

7 January 2021

based on heuristic

inferred from DOI database lookup

Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008299429294

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorouracil and high-dose leucovorin in previously untreated patients with advanced adenocarcinoma of the pancreas: results of a phase II trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008299429294

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trials of 5-fluorouracil and leucovorin in patients with metastatic gastric or pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008299429294

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin and protracted venous infusion 5-fluorouracil (CF)--good symptom relief with low toxicity in advanced pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008299429294

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuous 5-fluorouracil (5FU) infusion in carcinoma of the pancreas: a phase II study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008299429294

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008299429294

1 reference

Europe PubMed Central

27 July 2017

1 reference

Europe PubMed Central

27 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33499869&oldid=1606882576"